Therapy / Class:
Therapy:
Levofloxacin: Antibacterial
Ornidazole: Antiprotozoal/Antimicrobial
Class:
Levofloxacin: Fluoroquinolone Antibiotics
Ornidazole: Nitroimidazole Derivative
Spectrum of Coverage:
Gram-Positive Bacteria
- Enterococcus faecalis
- Staphylococcus aureus (methicillin-susceptible isolates)
- Staphylococcus epidermidis (methicillin-susceptible isolates)
- Staphylococcus saprophyticus
- Streptococcus pneumoniae (including multi-drug resistant isolates)
- Streptococcus pyogenes
Gram-Negative Bacteria
- Enterobacter cloacae
- Escherichia coli
- Haemophilus influenzae
- Haemophilus parainfluenzae
- Klebsiella pneumoniae
- Legionella pneumophila
- Moraxella catarrhalis
- Proteus mirabilis
- Pseudomonas aeruginosa
- Serratia marcescens
Other Bacteria
- Chlamydophila pneumoniae
- Mycoplasma pneumonia
Gram-positive anaerobes
- Clostridium species
- Eubacterium species
- Peptococcus species
- Peptostreptococcus species
Gram-negative anaerobes
- Bacteroides fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B.vulgatus)
- Fusobacterium species
Protozoal parasite
- Entamoeba histolytica
- Trichomonas vaginalis
- Giardia lamblia (Giardia intestinalis)
Mechanism of Action:
Levofloxacin: It is a L-isomer of the racemate, ofloxacin, a quinolone antimicrobial agent. The antibacterial activity of ofloxacin resides primarily in the L-isomer. The mechanism of action of levofloxacin and other fluoroquinolone antimicrobials involves inhibition of bacterial topoisomerase IV and DNA gyrase (both of which are type II topoisomerases), enzymes required for DNA replication, transcription, repair and recombination.
Ornidazole: It is a newer 5-nitroimidazole class of antibiotic with superior efficacy and longer duration of action. It has an antibacterial effect like that of metronidazole and other 5-nitroimidazoles. It kills susceptible microorganisms by interfering with DNA functioning. It acts selectively against microorganisms with enzyme systems capable of reducing the nitro group and catalyzing the interaction between ferredoxin proteins and nitro compounds. After the drug penetrates the microbial cell, the mechanism of its action is based on reducing the nitro group under the influence of the microorganism’s nitroreductases and the activity of the reduced nitroimidazole. The reduction products create compounds with DNA causing it to degrade and disrupt the DNA replication and transcription processes. Furthermore, the drug’s metabolism products have cytotoxic properties and disrupt cellular respiration processes.
Indications:
- Diarrhoea
- Dysentery
- Mixed Intra-Abdominal Infections
Dosage & Administration:
- 5ml BID for 3 to 5 Days
HOW SUPPLIED: LEFCLIN-O is available as suspension in pack of 60ml.
References:
- JETIR November 2021, Volume 8, Issue 11
- StatPearls Publishing; 2023 Jan.2022 Sep 23.
- Mil Med. Author manuscript; available in PMC 2018 September 01
- Clinical Infectious Diseases, Volume 37, Issue 9, 1 November 2003, Pages 1165–1171,